Threonine

Threonine

SCHEMBL6689276

C[C@@H](O)[C@H](N)C(=O)O.NCC(=O)OC(=O)CN.O=C(O)[C@@H]1CCCN1.O=C(OC1CCN[C@@H]1C(=O)O)[C@@H]1CCCN1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Threonine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL6690171 0.92 MEN1 (0.32)
SCHEMBL4398036 0.81 MEN1 (0.35)
Glycine SCHEMBL1675339 0.80 MEN1 (0.41)
Threonine SCHEMBL27639983 0.79 NOS2 (0.33)
Threonine SCHEMBL11969543 0.79 NOS2 (0.33)
Glutamine SCHEMBL8704393 0.78 MEN1 (0.33)
Glutamine SCHEMBL8700598 0.78 MEN1 (0.33)
Threonine SCHEMBL7041491 0.77 NOS2 (0.38)
Threonine SCHEMBL1887229 0.77 NOS2 (0.38)
Threonine SCHEMBL28397150 0.77 NOS2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110470-A2 USE OF COLLAGEN PEPTIDES TO INHIBIT INFECTION THE UNIVERSITY OF BRISTOL (GB) 2004-12-23 WO disclosed